baber/WOPTO huggingface dataset:
Patent PT-1581434-E (PT)
Title: Container
Inventor: MURJAHN KLAUS
IPC: B65D1/22
Filed: 2003-11-08
Abstract: The paint container (10) has a lid (18) with a rim (20) which seals it. The handle (14) swivels upwards and carries pins (26) on its sides which push the lid upwards to open the container.
Patent PT-1802750-E (PT)
Title: Phytases
Inventor: KETTLING ULRICH
IPC: A23K1/165
Filed: 2005-10-17
Abstract: The present invention relates to enzymes and processes. In particular, there is described a host cell transformed or transfected with a nucleic acid encoding a bacterial phytase enzyme and variants thereof.
Patent PT-1741573-E (PT)
Title: Gap cover for articulated vehicles
Inventor: KOCH ROBERT
IPC: B61D17/22
Filed: 2006-05-31
Abstract: The cover (12) has singular pleats (13) provided such that adjacent pleats are joined together by clamping ledges (16) in a region of an apex (14a). The clamping ledges are fastened at both ends to a side wall of bellows of a connection so as to be vertically movable. Sheaths are disposed in the region of a portion of the side wall. The sheaths are clampingly connected to the pleats or corrugations of the bellows. An edging tape is bent in a U-shape and is glued and/or sewn to webs (13a) of the pleats. A bent bar (30) has aligned ends (31) screwed to a central frame of the connection.
Patent PT-1710187-E (PT)
Title: Multiple folding machine
Inventor: SCHREIBER KLAUS-PETER
IPC: B65H45/18
Filed: 2006-03-13
Abstract: The combination paper folding machine has blade folding units and sliding carriages (40) mounted downstream from them. Cutter spindles or folding rollers (46) are mounted on these.
Patent PT-1909522-E (PT)
Title: Mobile station, wireless access network apparatus, mobile communication system and communication method for controlling transmission timing
Inventor: IISHII MINAM
IPC: H04W72/12
Filed: 2006-07-25
Abstract: A mobile communication system is provided that performs bi-directional communications between a mobile station and a wireless access network device. The mobile station includes a connection set-up signal reception timing calculation unit for calculating a reception timing of a connection set-up signal when a connection request signal is transmitted, and a connection set-up signal reception determination unit that determines, according to the reception timing, whether the connection set-up signal is received, and performs a signal reception operation based on the determination. The wireless access network device includes a connection set-up signal scheduling unit that, after receiving a connection request signal from the mobile station, performs a connection set-up signal transmission assignment based on a reception timing of the connection request signal, a connection set-up signal generation unit that generates a connection set-up signal to be sent to the mobile station; and a connection set-up signal transmission unit that transmits the connection set-up signal based on the connection set-up signal transmission assignment.
Patent PT-1987086-E (PT)
Title: Method for the preparation of fluoropolymer powdered materials
Inventor: COATES MICHAEL
IPC: C08J3/12
Filed: 2007-01-16
Abstract: A method for the preparation of fluoropolymer powdered materials is disclosed. A suspension of solid fluoropolymer particles in a liquid carrier, preferably water, is frozen and the frozen carrier is then removed by sublimation at sub-atmospheric pressure to produce a dry powder of fluoropolymers particles.
Patent PT-2019895-E (PT)
Title: Hinge structure for self-closing doors or the like, particularly glass doors or the like, and assembly incorporating such structure
Inventor: GOSIO DIANORA
IPC: E05F3/20
Filed: 2007-05-03
Abstract: A hinge structure (1) for self-closing doors or the like comprises a first stationary element (2) attachable to the frame (T) of a door (P), a first movable element (3) securable to the door (P) and pivotally mounted to the first stationary element (2) for rotating about a longitudinal axis (X) between an open door position and a closed door position. The structure (1) further comprises closing means (4) acting on the first movable element (3) for automatically returning the door (P) to the closed position during opening, hydraulic damping means (5) operating on the first movable element (3) to oppose and damp the movement produced by the closing means (4). The closing means (4) and the hydraulic damping means (5) are housed within a first operating chamber (6) locate internally of the first stationary element (2). An assembly incorporates such hinge structure.
Patent PT-2439188-E (PT)
Title: P-menthane-3,8-diol derivatives and insect repellents comprising them
Inventor: RATAJ-NARDELLO VERONIQUE
IPC: A01N31/04
Filed: 2010-09-15
Abstract: Para-menthan-3,8-diol derivatives (I) are new. Para-menthan-3,8-diol derivatives of formula (I) are new. R : optionally saturated 2-6C-alkyl or 2-6C-acyl (both optionally substituted with at least one functional group comprising CO 2M, SO 3M, PO 4M or NH 3 +>X ->); M : H or an alkali metal; and X ->halide. Independent claims are included for: (1) an aqueous solution comprising (I); and (2) the preparation of (I). [Image] - ACTIVITY : Insect Repellent. - MECHANISM OF ACTION : None given.
Patent PT-2682778-E (PT)
Title: Method for detecting a wheel of a vehicle
IPC: G01S13/91
Filed: 2012-07-06
Abstract: A rotating wheel of a vehicle is detected by evaluating the Doppler shift of a measuring beam, which is emitted by a detector unit passed by the vehicle, and is reflected by the wheel and returned in Doppler-shifted form. In a relative position to the wheel, the vehicle comprises an onboard unit, which can establish radio communication with a transceiver having a known location in the detector unit. The direction and distance of the onboard unit from the transceiver are measured on the basis of at least one radio communication between the same. The radiation direction or radiation position of the measuring beam is controlled in accordance with the measured direction and distance and taking into consideration the aforementioned relative position and location.
Patent PT-631626-E (PT)
Inventor: GRUSS ALEXANDRA
IPC: C12N1/21
Filed: 1993-03-12
Abstract: PCT No. PCT/FR93/00248 Sec. 371 Date Dec. 27, 1994 Sec. 102(e) Date Dec. 27, 1994 PCT Filed Mar. 12, 1993 PCT Pub. No. WO93/18164 PCT Pub. Date Sep. 16, 1993A bacterial vector plasmid of the type having an efficient replication origin in Gram-positive bacteria. The plasmid is characterized by having at least one marker gene which expresses itself in a bacterial host strain, an efficient replication system which is thermosensitive based on a temperature compatible with the viability of the host strain, and in that the temperature of replication inhibition is below or equal to approximately 37 DEG  C. The invention also concerns bacteria containing the plasmid and a process for inactivating a gene in the chromosome of a bacterium.
Patent PT-678534-E (PT)
Inventor: HUBERTUS KRONER DR
IPC: C08F261/06
Filed: 1995-04-15
Abstract: Gels for thermotropic sheets are claimed which are obtd. by light-radiation of a mixt. comprising (A) a non-crosslinked polymer (pref. 5-40 wt.%); (B) a radically-polymerisable monomer (pref. 1-30 wt.%); and (C) water and/or an org. solvent (pref. 30-94 wt.%). Pref. a photoinitiator is opt. also present. Polymer (A) has transparency changes in a 10 wt.% aq. and/or org. solvent soln. and is poly-N-vinylcaprolactam, a copolymer contg. at least 20 wt.% N-vinylcaprolactam, or a polyvinylether. Monomer (B) forms a 3-D network on light-irradiation and ether does not have thermotropic properties of the type specified above or has such properties at at least 20 degrees C above the switching region for polymer (A). (C) is water.
Patent PT-778302-E (PT)
Inventor: BROENNUM THOMAS
IPC: C08G18/28
Filed: 1996-12-05
Abstract: Polyether polyol having an aromaticity in the range of from 2% to 35%, an average nominal functionality (Fn) in the range of from 2.0 to 4.5 and a hydroxyl value in the range of from 390 to 650 mg KOH/g, whereby the aromatic carbon atoms are contained in structural moieties of the general formula <CHEM> wherein both R1 groups independently represent hydrogen or a C1-C3 alkyl group; both R2 groups independently represent a C1-C3 alkyl group; and n is an integer of from 0 to 3. Process for the preparation of the above polyether polyol, which process comprises reacting an alkylene oxide with a polyhydric alcohol blend comprising a diphenylol alkane precursor of the above indicated structural moiety and at least one aliphatic or alicyclic polyhydric alcohol having a functionality of at least 2.0. Polyether polyol blend having an aromaticity in the range of from 2 to 10% and a Fn in the range of from 2.5 to 5.0 eq/mole, which blend comprises the above polyether polyol and one or more aliphatic or alicyclic polyether polyols having a Fn of at least 2.5. Rigid polyurethane foam having a total aromaticity in the range of from 35% to 50%, obtainable by foaming a composition comprising the above polyol or polyol blend having an aromaticity from 2 to 10% and a Fn from 2.5 to 5.0 eq/mole, and an aromatic polyisocyanate in such amount that the isocyanate index is from 100 to 150, whereby the polyol reactant accounts for from 1 and 10% of the total aromaticity of the rigid polyurethane foam.
Patent PT-721989-E (PT)
Inventor: POPOFF MICHEL YVAN
IPC: C12Q1/689
Filed: 1996-01-15
Abstract: A novel nucleotide sequence (I), involved in invasion of cultured HeLa cells by Salmonella enterica ssp. enterica serovar. typhi (S. typhi), is either the 97-1755 or 1766-2255 region (designated iagA and iagB, respectively) of an approx. 2.4 kb. sequence reproduced.
Patent PT-749758-E (PT)
Inventor: HJERTMAN BIRGER
IPC: A61M5/20
Filed: 1996-06-20
Abstract: Disclosed are methods and means for facilitating injection which enable a correct penetration depth of the needle. These improvements are obtainable by using a needle covering device comprising an axially displaceable first tubular sleeve (30) arranged around the front part of said injection apparatus which at its foremost part surrounds the needle (11) over its entire length, and while overcoming a spring force, is axially displaceable rearwards to expose a predetermined length of the needle, said device further comprises a stationary outer tubular sleeve (40) releasably attached to the injection apparatus and fitted around the front part of said injection apparatus and an inner adjustable tubular stopping sleeve (20) which is axially displaceable between at least two predetermined positions while performing a sliding, helical motion around said front part of said injection apparatus when setting the distance between the foremost part of said stopping sleeve and a stopping flange (31) arranged on the inside of the axially displaceable first sleeve. <IMAGE>
Patent PT-833646-E (PT)
Inventor: COY DAVID HOWARD
IPC: A61K51/00
Filed: 1996-06-03
Abstract: Disclosed are methods and compositions for the diagnosis and treatment of diseases associated with aberrant expression of a somatostatin receptor (e.g., cancer) or with increased production of a factor regulatable by somatostatin (e.g., acromegaly). The compounds of the invention are of the general formulae:   <IMAGE>   wherein P is a somatostatin peptide analog which binds to a somatostatin receptor, Y is D-tyrosine, L-tyrosine, or desamino-tyrosine, n is an integer from 1 to 32, inclusive, each q, independently, is an integer from 1 to 32, inclusive, and each s, independently, is an integer from 1 to 32, inclusive, where q and s can be the same or different, and X is of the formulaD-NH2-CH(CH2)mNH2-CO2H orL-NH2-CH(CH2)mNH2-CO2H,wherein m is an integer from 1 to 10, inclusive.
Patent PT-861357-E (PT)
Inventor: ERIKSSON BERTIL
IPC: E03C1/122
Filed: 1996-10-29
Abstract: PCT No. PCT/SE96/01383 Sec. 371 Date Apr. 30, 1998 Sec. 102(e) Date Apr. 30, 1998 PCT Filed Oct. 29, 1996 PCT Pub. No. WO97/16608 PCT Pub. Date May 9, 1997The drain system in a building is divided in at least two parts, namely a first part (2) arranged to receive drain water contaminated to a relatively high degree from one or a plurality of first units (3), and a second part (10) arranged to receive drain water normally contaminated to a lower degree from one or a plurality of second units (11, 12). The second drain system part (10) comprises at least one drain conduit (13) and at least one unit (11) connected thereto and so constructed that it lacks traps preventing a flow of air therethrough. An apparatus (16) is connected to the drain conduit (13), for generating such a negative pressure in the drain conduit giving rise to an evacuating flow of air from the room in question in the building through the at least one unit (11) and through the drain conduit (13).
Patent PT-1001820-E (PT)
Inventor: DAN DANIELS
IPC: A61M5/32
Filed: 1999-05-14
Abstract: A sharps container for receiving and storing medical sharps and waste materials which prevents hand access to within the container and has a wide access opening. The container (10) comprises a receptacle (11) having an opening which is closable toy a hinged lid (24) which is movable between opened and closed positions. A pivotal tray (16) is mounted at the opening wherein for the opened position of the lid (24) the tray (16) has a rest position at which it is accessible for medical sharps and waste materials to be placed thereon. The tray (16) is then pivotally moveable for disposal of the medical sharps and waste materials therefrom into the receptacle. The tray (16) is arranged such that as it pivots a front edge thereof moves towards the opened lid (24), and a rear edge (23) thereof moves closely adjacent a guard (35), wherein the rear edge (23) clears the guard (35) for disposal of medical sharps and waste materials into the receptacle from the tray (16) when the front edge of the tray is proximate the lid (24), thereby preventing hand access to within the receptacle (11) for all positions of the tray (16) about its pivotal axis. The tray (16) is biased to return to its rest position. The lid (24) and tray (16) are operatively associated such that as the lid is opened from a closed position, the tray (16) is moved from a storage position within the receptacle (11) to its rest position. The tray (16) is foldable to facilitate its storage within the receptacle (11) upon closing the lid (24).
Patent PT-1102724-E (PT)
Inventor: VOLKMAR PEUKERT DR
IPC: C02F3/28
Filed: 1999-07-02
Abstract: The invention relates to a method and installation for treating waste water from oil seed and cereal processing, especially olive oil mill waste water (OMW), guaranteeing a substantial reduction of environmentally damaging waste water ingredients while taking economic factors into account. The aim of the invention is to develop a method and system designed to treat olive oil mill waste water, whereby higher physical, chemical, biochemical and biological elimination rates can be achieved using the material and energy potential of the OMW while taking economic aspects into account. The installation needs to be able to operate at short notice due to the amounts of seasonal waste. In the inventive method and installation thus disclosed, the fresh waste water is pre-treated by subjecting it to acidification with biogenic flocculation and separation of solid particles. The pre-treated waste water is then anaerobically and mesophilically processed using a carrier-bound biomass suspension, whereby fixing occurs using moving bed biofilm biology with cylindrical hollow bodies acting as a carrier material and the biogas thus arising, in addition to the sludge thus occurring, is removed.
Patent SG-82483-G (SG)
Title: (d1)-16-phenoxy-and 16-substituted phenoxy-9-keto prostatrienoic acid derivatives and processes for the production thereof
IPC: C07C401/00
Filed: 1983-12-27
Abstract: Novel 16-phenoxy and 16-(o, m or p)-substituted phenoxy derivatives of (dl)-9-keto-11 alpha ,15 alpha -dihydroxy-17,18,19,20-tetranorprosta-4,5,13-trans-trienoic acid, the pharmaceutically acceptable, non-toxic lower alkyl esters and salts thereof and processes for the production of such compounds. These compounds possess prostaglandin-like activities and thus are useful in the treatment of mammals where prostaglandins are indicated. They are particularly useful as inhibitors of gastric acid secretion; and as agents for the control of asthmatic attack, because of their bronchodilating activity.
Patent IE-37291-L (IE)
Title: Mineral salt preparation
IPC: A61K33/42
Filed: 1973-02-19
Abstract: 1356096 Mineral salt preparations F HOFFMANN-LA ROCHE & CO AG 23 Feb 1973 [25 Feb 1972] 9053/73 Heading A5B Mineral salt preparations for the replacement of minerals lost by bodily stress and increased transpiration as well as by the use of diuretics, contain in the form of salts, 1 to 16 parts by weight of calcium, 1 to 8 parts by weight of magnesium, 0.4 to 4 parts by weight of potassium and no sodium or less than 0.1 parts by weight of sodium, the calcium, potassium, magnesium and sodium constituting more than 2% by weight of the preparation. The salts may be the appropriate carbonates, phosphates, glycerophosphates, gluconates, ascorbates or D-pantothenates. The preparations may be administered orally in the form of powders, granulates, tablets (e.g. effervescent tablets), drag es, capsules, solutions, suspensions or emulsions. The preparations may also contain phosphates, vitamins, e.g. vitamin C, B 1 , B 2 , B 6 and E, nicotinic acid, nicotinamide, pantothenic acid and/or calcium D-pantothenate; sugars, e.g. glucose, lactose, fructose, saccharose, laevulose, mannitol, sorbitol or xylitol; sweetening agents; aroma additives; acid additives, e.g. citric or tartaric acid, colouring agents; solubilising agents; granulating adjuvants, preservatives; stabilisers; wetting agents; emulsifiers; salts for varying the osmotic pressure and/or buffers.
[GB1356096A]
Patent FI-831422-L (FI)
Inventor: JANSSEN WILHELMUS GERARDUS ELI
IPC: B28C5/46
Filed: 1983-04-26
Abstract: A process and apparatus for the preparation of mortar from an aggregate and a binder is disclosed which comprises the use of a silo provided with at least one partition so as to create in the silo two or more compartments for the separate storage of the aggregate and the binder, the compartments being provided with conveyor screws, the speeds of which can be adjusted to control the volumetric flow of the components to a mixing chamber. A metering valve for water may also be connected to the mixing chamber. The silo compartment for the aggregate may be provided with a heating element to safeguard the mechanically operated slide valve against freezing. The conveyor screw in the outlet for the binder may be provided with a cam and a plunger rod with transverse projections to prevent arching in the compartment for the storage of the binder. The apparatus may be mounted on a truck to facilitate transport to the building site.
Patent FI-832525-L (FI)
Inventor: GRUENFELD DETMAR
IPC: B62K19/18
Filed: 1983-07-11
Abstract: PCT No. PCT/DE82/00216 Sec. 371 Date Jul. 12, 1983 Sec. 102(e) Date Jul. 12, 1983 PCT Filed Nov. 11, 1982 PCT Pub. No. WO83/01763 PCT Pub. Date May 26, 1983.A connection between at least one first tube and a second tube of a bicycle frame includes a flared terminus forming part of an end portion of the first tube. The flared terminus is in engagement with an outer surface of the second tube. An injection-molded one-piece plastic casing fully surrounds the end portion of the first tube and fully surrounds a circumferential portion of the outer surface of the second tube in a zone of the flared terminus.
Patent FI-850759-L (FI)
Inventor: JONES WILLIAM EDWARD
IPC: C07J71/00
Filed: 1985-02-25
Abstract: The present invention relates to a steroid compound of the formula:   <CHEM> which because of its enhanced activity compared with its parent compound trilostane is particularly suitable for use in a method of treatment of the human or animal body by therapy, and especially in therapy to modulate or inhibit adrenal steroidogenesis. The compound may be presented in various forms and is prepared by a process which comprises opening the isoxazole ring of a compound of the formula: <CHEM> in particular by treatment with a strong base.
Patent IE-891022-L (IE)
Title: Diagnosis of mycobacterium bovis infection
IPC: C07K16/12
Filed: 1989-03-30
Abstract: A method for the diagnosis of Mycobacterium bovis infection in a susceptible animal, comprises detection in said animal of antibodies against the MPB-70 protein of M.bovis and/or the detection of a cell-mediated immune response of said animal to the said MPB-70 protein. Also disclosed is a recombinant DNA molecule corresponding to all or portion of the M.bovis DNA sequence coding for the MPB-70 protein or a polypeptide having the antigenicity of MPB-70 protein, or degenerate forms thereof, as well as recombinant MPB-70 protein or polypeptide and a process for the preparation thereof.
[WO8909261A1]
Patent IE-33498-L (IE)
Title: Benzenesulphonyl ureas
IPC: C07D233/96
Filed: 1969-07-24
Abstract: 1,233,354. Benzenesulphonyl-ureas. FARBWERKE HOECHST A.G. 14 Feb., 1969 [2 Aug., 1968], No. 8218/69. Heading C2C. Novel compounds I (including salts thereof) wherein X signifies the groups II or III in which R signifies C 1-4 alkyl, Z signifies halogen, C 1-4 alkyl or C 1-4 alkoxy and Z<SP>1</SP> signifies halogen or C 1-4 alkyl are obtained according to standard methods. N - [4 - (# - Aminoethyl) - benzenesulphonyl]. N<SP>1</SP> - (#<SP>2</SP> - cyclohexenyl) - urea is prepared by saponifying the #-acetamidoethyl-compound. 1 - [4 - (# - < 2 - Methoxy - 5 - chlorobenzamido > - ethyl) - benzenesulphonyl] - 3 - (#2. cyclohexenyl)-parabanic acid is prepared by the interaction of 1-(#2-cyclohexenyl)-parabanic acid and 4 - (# - < 2 - methoxy - 5 - chlorobenzamido > - ethyl) - benzenesulphochloride. #2 - Cyclohexenyl isocyanate is prepared by heating N - (#2 - cyclohexenyl) - N<SP>1</SP>,N<SP>1</SP> - diphenyl-urea. The cyclohexenylamine salt of N-[4 - (# - < 2- methoxy - 5 - chlorobenzamido > - ethyl) - benzenesulphonyl] - N<SP>1</SP> - aceryl - urea is obtained by mixing the individual compounds and heating. N - (#2 - Cyclohexenyl) - carbamic acid phenyl ester is prepared by the interaction of phenyl chloroformate and #2-cyclohexenylamine. N - Acetyl - N<SP>1</SP> - (#2 - cyclohexenyl) - urea is prepared by the interaction of acetic anhydride and #2-cyclohexenyl-urea. N,N - Diphenyl - N<SP>1</SP> - (#2 - cyclohexenyl)- urea is prepared from diphenyl carbamoyl chloride and #2-cyclohexenylamine. N,N<SP>1</SP> - Di - (#2 - cyclohexenyl) - urea is prepared from #2 - cyclohdxenyl isocyanate and #2-cyclohexenylamine. N - [4 - (# - < 2 - Methoxy - 5 - chlorobenzamido > - ethyl) - benzenesulphonyl] - phenylurethane, -N<SP>1</SP>N<SP>1</SP> - diphenyl - urea, - iminodithio - carbonic acid potassium salt and dimethyl ester, -N<SP>1</SP> - (#2 - cyclohexenyl) - isothiourea methyl ether, -N<SP>1</SP>-(#2-cyclohexenyl)- thiourea and - N<SP>1</SP> - (#2 - cyclohexenyl) - isourea methyl ether and 4-(#-<2-methoxy-5-chlorobenzamido > - ethyl) - benzene sulphonamide are also prepared as intermediates. Pharmaceutical preparations exhibiting blood sugar lowering properties and hypoglycemic activity contain I as active ingredient; administration is orally.
[GB1233354A]